Price Alert

Kestra Medical Technologi... (KMTS)

NASDAQ: KMTS · Real-Time Price · USD

16.09

0.13 (0.81%)

At close: Aug 15, 2025, 12:11 PM

Kestra Medical Common Stock Statistics

Share Statistics

Kestra Medical Common Stock has 51.35M shares outstanding. The number of shares has increased by null% in one year.

Shares Outstanding	51.35M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Institutions (%)	90%
Shares Floating	n/a
Failed to Deliver (FTD) Shares	5,004
FTD / Avg. Volume	1.53%

Short Selling Information

The latest short interest is 2.29M, so 4.47% of the outstanding shares have been sold short.

Short Interest	2.29M
Short % of Shares Out	4.47%
Short % of Float	9.6%
Short Ratio (days to cover)	6.44

Valuation Ratios

The PE ratio is -10.47 and the forward PE ratio is -4.77. Kestra Medical Common Stock's PEG ratio is -0.07.

PE Ratio	-10.47
Forward PE	-4.77
PS Ratio	19.92
Forward PS	8.8
PB Ratio	5.8
P/FCF Ratio	-11.78
PEG Ratio	-0.07

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Kestra Medical Common Stock.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.72, with a Debt / Equity ratio of 0.22.

Current Ratio	6.72
Quick Ratio	6.55
Debt / Equity	0.22
Debt / EBITDA	-0.45
Debt / FCF	-0.44
Interest Coverage	-13.75

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$199.38K
Profits Per Employee	$-379.38K
Employee Count	300
Asset Turnover	0.2
Inventory Turnover	5.42

Taxes

Income Tax	135K
Effective Tax Rate	-0.12%

Stock Price Statistics

The stock price has increased by null% in the last 52 weeks. The beta is 0, so Kestra Medical Common Stock's price volatility has been lower than the market average.

Beta	0
52-Week Price Change	n/a
50-Day Moving Average	17.04
200-Day Moving Average	n/a
Relative Strength Index (RSI)	37.72
Average Volume (20 Days)	328,100

Income Statement

In the last 12 months, Kestra Medical Common Stock had revenue of 59.81M and earned -113.81M in profits. Earnings per share was -5.13.

Revenue	59.81M
Gross Profit	24.21M
Operating Income	-106.38M
Net Income	-113.81M
EBITDA	-97.98M
EBIT	-105.94M
Earnings Per Share (EPS)	-5.13

Full Income Statement

Balance Sheet

The company has 237.59M in cash and 44.31M in debt, giving a net cash position of 193.28M.

Cash & Cash Equivalents	237.59M
Total Debt	44.31M
Net Cash	193.28M
Retained Earnings	-520.25M
Total Assets	295.74M
Working Capital	217.35M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -77.61M and capital expenditures -23.59M, giving a free cash flow of -101.2M.

Operating Cash Flow	-77.61M
Capital Expenditures	-23.59M
Free Cash Flow	-101.2M
FCF Per Share	-2.04

Full Cash Flow Statement

Margins

Gross margin is 40.47%, with operating and profit margins of -177.85% and -190.28%.

Gross Margin	40.47%
Operating Margin	-177.85%
Pretax Margin	-190.05%
Profit Margin	-190.28%
EBITDA Margin	-163.8%
EBIT Margin	-177.85%
FCF Margin	-169.19%

Dividends & Yields

KMTS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for KMTS is $27.5, which is 87.6% higher than the current price. The consensus rating is "Buy".

Price Target	$27.5
Price Target Difference	87.6%
Analyst Consensus	Buy
Analyst Count	5

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	2.4
Piotroski F-Score	3